I see nothing from a charting or fundamental perspective to warrant a "sell" on STU - headed higher imo.But ... who knows - my 'tea leaves' could be wrong.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025